Pharmacokinetic characterization of a human immunodeficiency virus protease inhibitor, saquinavir, during ethanol intake in rats
Throughout therapeutic drug monitoring of human immunodeficiency virus (HIV) protease inhibitors in HIV‐infected patients, it was found that plasma concentrations of saquinavir (SQV) were reduced in patients who had a habit of alcohol intake during double protease therapy with SQV and ritonavir (RTV...
Saved in:
Published in | Biopharmaceutics & drug disposition Vol. 24; no. 8; pp. 335 - 344 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Chichester, UK
John Wiley & Sons, Ltd
01.11.2003
Wiley |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!